We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Combining Tests Leads to Better Prediabetes Detection

By LabMedica International staff writers
Posted on 16 Dec 2015
The application of a screening test that is both robust and handy is vital for promptly ascertaining subjects with prediabetes. More...
A robust and quick prediabetes diagnostic test can reduce overall societal costs of diabetes by motivating subjects with prediabetes to seek diabetes preventative care.

Fasting plasma glucose (FPG) and oral glucose tolerance (OGT) tests are greatly used in screening and diagnosing type 2 diabetes and while the OGT test is mostly recognized as the benchmark for diagnosing type 2 diabetes, but the test is laborious and uncomfortable to patients.

Scientists at Georgia State University (Atlanta, GA, USA) studied a group of participants whose ages ranged from 12 to 75 years with no missing values for age, height, weight, and assayed for OGT, FPG and HbA1c. Subjects were categorized as nondiabetic if they had FPG of less than 25 mg/dL or FPG of less than 199 mg/dL on a two-hour OGT test and HbA1c less than 6.5%. Prediabetes comprises impaired fasting glucose (IFG) expressed as FPG 100–125 mg/dL, impaired glucose tolerance (IGT) as OGT of 140–199 mg/dL, and HbA1c 5.7–6.4%.

The scientists found that the joint use of FPG and HbA1c test was associated with significantly higher proportion of subjects with prediabetes across age, race/ethnicity and BMI as compared to combined use of OGT and FPG, OGT and HbA1c. Overall prevalence of prediabetes using OGT + FPG, OGT + HbA1c, HbA1c + FPG, and OGT + FPG + HbA1c tests were 20.3%, 24.2%, 33%, and 34.3%, respectively. The study indicates prediabetes rates were higher using HbA1c + FPG tests compared to the traditionally used OGT + FPG tests.

The authors concluded that using a combination of HbA1c and FPG test in screening for prediabetes provides the benefits of individual test and decreases the risk of systematic bias inherent in using only HbA1c testing. This study proposes the need to redefine a basic and a practical way on the application of HbA1cin screening for prediabetes. The use of HbA1c test in detection of prediabetes in population and clinical settings should take into account patient race/ethnicity, gender, age, and body mass index (BMI). The study was published November 20, 2015, in the journal Frontiers in Public Health.

Related Links:

Georgia State University 



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Melanoma Panel
UltraSEEK Melanoma Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.